Year: 2026
Type: article
Abstract: To the Editor, We read with interest the recent Infectious Diseases Society of America (IDSA)-led multisociety position paper on hospital sepsis strategies [1] and would like to raise a question about the recommendations of antibiotic-timing.In 2018, the IDSA declined to endorse the Surviving Sepsis Campaign (SSC) guideline, citing concerns that rigid, fixed time-from-recognition antibiotic targets would drive overuse of broad-spectrum agents among patients with noninfectious sepsis-mimicking syndromes "in the rush to meet the fixed frame" [2] , together with ambiguity in defining "time zero" for quality measurement.Analyses of Centers for Medicare and Medicaid Services (CMS) SEP-1 implementation subsequently documented increased hospital-wide broad-spectrum antibiotic use, although the measure's stewards disputed the interpretation of these findings [3,4] .IDSA's position paper on SEP-1 accordingly proposed removing time-based performance targets for sepsis without shock, reserving mandatory timing -----------------------------
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciag735
Authors: Yuan-Yuan Li, Guang-Yun Liu, Ji-Cheng Zhang, Bin Du
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7235999378
